Greater Bay Area

Explore the landscape of Greater Bay Area in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Greater Bay Area to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Tigermed Posts 14% Revenue Growth in 2026 Interim Results – China’s No.1 Clinical CRO Sees Bookings Rebound While Fair‑Value Losses Swing Reported Profit Negative

Hangzhou Tigermed Consulting Co., Ltd. (HKG: 3347, SHE: 300347), China's largest clinical contract research organization (CRO), released its unaudited interim results for the six months ended 30 June 2026. Revenue…

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.